|
1. Ivanisenko N, Seyrek K, Hiller-Richter L, König C, Espe J, Bose K, Lavrik I (2021). Regulation of extrinsic apoptotic signaling by c-FLIP: towards targeting cancer networks. Trends in Cancer.
2. Panda G, Kalra B, Rishi A, Khanna N, Kakoti S, Sridhar E, Shet T, Sengar M, Nayak L, Bagal B, Jain H, Laskar S, Goda J (2021). Long-term clinical outcomes and sequelae of therapy in early-stage orbital mucosa-associated lymphoid tissue lymphoma. Clinical Lymphoma Myeloma and Leukemia.
3. Chaturvedi P, Badwe RA (2021). With the emergence of Omicron, SARS-CoV-2 is getting weaker and human species is getting stronger due to our inherent cellular intelligence. Cancer Research, Statistics and Treatment .4: 608-10.
4. Dhumal S, Patil V, Noronha V, Joshi A, Menon N, Nawale K, Tambe R, Prabhash K (2021). Post hoc analysis of the screening log of phase III investigator-initiated randomized clinical trial comparing palliative oral metronomic versus intravenous chemotherapy in head-and-neck cancer. Cancer Research Statistics, and Treatment. 4: 642-6.
5. Rao AR, Gattani S, Castelino R, Kumar S, Dhekale R, Krishnamurthy J, Ramaswamy A, Noronha V, Gota V, Banavali S, Badwe RA, Prabhash K (2021). Utilization of technology among older Indian patients with cancer: A cross-sectional study. Cancer Research Statistics, and Treatment. 4:656-62.
6. Badwe RA, Parmar V, Nair NS (2021). Predicting pathological complete response post neoadjuvant chemotherapy and personalizing therapy in breast cancer. Cancer Research Statistics, and Treatment . 4:726-7.
7. Mirgh SP. (2021). (F)utility of day 14 bone marrow in acute myeloid leukemia on 3 + 7 induction – Is it time to bid adieu to day 14 bone marrow?. Cancer Research Statistics, and Treatment. 4:731-3.
8. Pimple S, Mishra GA (2021). Need more evidence for establishing standard vaccination practices among patients with cancer. Cancer Research Statistics and Treatment. 4:804-5.
9. MG Sudharsan M, Chikhale R, Nanaware N, Dalvi S, Venkatraman P (2022). A druggable pocket on PSMD10Gankyrin that can accommodate an interface peptide and doxorubicin. European Journal of Pharmacology. 915: 174718.
10. Pansare K, Mohanty B, Dhotre R, Pettiwala AM, Parab S, Gupta N, Gera P, Gardi N, Dugge R, Sahu P, Alhans R, Kowtal P, Chaudhari P, Sarin R (2022). Aspirin Inhibition of Group VI Phospholipase A2 Induces Synthetic Lethality in AAM Pathway Down-Regulated Gingivobuccal Squamous Carcinoma. Cells. 11(1):123.
11. Castaño-Vinyals G, Sadetzki S, Vermeulen R, Momoli F, Kundi M, Merletti F, Maslanyj M, Calderon C, Wiart J, Lee AK, Taki M, Sim M, Armstrong B, Benke G, Schattner R, Hutter HP, Krewski D, Mohipp C, Ritvo P, Spinelli J, Lacour B, Remen T, Radon K, Weinmann T, Petridou ET, Moschovi M, Pourtsidis A, Oikonomou K, Kanavidis P, Bouka E, Dikshit R, Nagrani R, Chetrit A, Bruchim R, Maule M, Migliore E, Filippini G, Miligi L, Mattioli S, Kojimahara N, Yamaguchi N, Ha M, Choi K, Kromhout H, Goedhart G, 't Mannetje A, Eng A, Langer CE, Alguacil J, Aragonés N, Morales-Suárez-Varela M, Badia F, Albert A, Carretero G, Cardis E (2022). Wireless phone use in childhood and adolescence and neuroepithelial brain tumours: Results from the international MOBI-Kids study. Environment International. 160:10769.
12. Halmare N, Gaonkar PP, Sonkusale PM, Somkuwar AP, Ingle AD, Kurkure NV (2021).Evaluation of anti-cancer activity of Tinospora cordifolia on experimentally induced spontaneous fibrosarcoma in Swiss albino mice. Indian Journal of Veterinary Pathology. 45(1): 15-23.
Book Chapters
1. Yogi K, Thorat R, Shirsat NV. (2022) In Vivo Tumorigenicity Assays Using Subcutaneous and Orthotopic Xenografts in Immunodeficient Mice. In: Dey A, Malhotra A, Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
2. Panwalkar P, Khire A, Shirsat NV. (2022) Quantification of microRNAs in Cells and Tissues Using Stem-Loop RT PCR and qPCR. In: Dey A, Malhotra A, Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
3. Panwalkar P, Khire A. Shirsat NV. (2022) Validation of microRNA Target Genes Using Luciferase Reporter assay and Western Blot Analysis. In: Dey A., Malhotra A., Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
4. Kunder R, Shirsat NV. (2022) Real-Time PCR Assays on Formalin-Fixed, Paraffin-Embedded Medulloblastomas. In: Dey A, Malhotra A, Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
5. Chatterjee A, Maitre M, Dasgupta A, Sridhar E, Gupta T. (2022) Multidisciplinary Management of Medulloblastoma: Consensus, Challenges, and Controversies. In: Dey A., Malhotra A., Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
6. Dasgupta A, Maitre M, Pungavkar S, Gupta T. (2022) Magnetic Resonance Imaging in the Contemporary Management of Medulloblastoma: Current and Emerging Applications. In: Dey A, Malhotra A, Garg N. (eds) Medulloblastoma. Methods in Molecular Biology, vol 2423. New York; Humana. (ISBN 978-1-0716-1952-0)
|
